The generation of memory B cells is maintained, but the antibody response is not, in the elderly after repeated influenza immunizations.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Vaccine

• Publication date

  2016-05-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2016.04.023PMID 27108193PMCID PMC4876633
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Obesity decreases B cell responses in young and elderly individuals

  2016cited by this paper
• MicroRNAs miR-155 and miR-16 Decrease AID and E47 in B Cells from Elderly Individuals

  2015cited by this paper
• Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.

  2015cited by this paper
• High Preexisting Serological Antibody Levels Correlate with Diversification of the Influenza Vaccine Response

  2015cited by this paper
• Plasma cell numbers decrease in bone marrow of old patients

  2015cited by this paper
• Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines

  2014cited by this paper
• Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.

  2014cited by this paper
• Memory B cells form in aged mice despite impaired affinity maturation and germinal center kinetics.

  2014cited by this paper
• High TNF-α levels in resting B cells negatively correlate with their response.

  2014cited by this paper
• AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial.

  2013cited by this paper
• Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011–2012 influenza vaccine season

  2013cited by this paper
• Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine.

  2013cited by this paper
• One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies.

  2012cited by this paper
• Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine.

  2012cited by this paper
• AID Activity in B Cells Strongly Correlates with Polyclonal Antibody Affinity Maturation in-vivo Following Pandemic 2009-H1N1 Vaccination in Humans

  2012cited by this paper
• Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender.

  2012cited by this paper
• Influenza Virus H1N1pdm09 Infections in the Young and Old: Evidence of Greater Antibody Diversity and Affinity for the Hemagglutinin Globular Head Domain (HA1 Domain) in the Elderly than in Young Adults and Children

  2012cited by this paper
• Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies.

  2011cited by this paper
• Influenza vaccine responses in older adults.

  2011cited by this paper
• Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans.

  2010cited by this paper
• Immunosenescence: what does it mean to health outcomes in older adults?

  2009cited by this paper
• Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

  2008cited by this paper
• Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses

  2008cited by this paper
• Aging Down-Regulates the Transcription Factor E2A, Activation-Induced Cytidine Deaminase, and Ig Class Switch in Human B Cells1

  2008cited by this paper
• Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?

  2008cited by this paper
• Immunosenescence: role and measurement in influenza vaccine response among the elderly.

  2007cited by this paper
• Mortality benefits of influenza vaccination in elderly people: an ongoing controversy.

  2007cited by this paper
• Duration of humoral immunity to common viral and vaccine antigens.

  2007cited by this paper
• Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers.

  2006cited by this paper
• Antibody response to influenza vaccination in the elderly: a quantitative review.

  2006cited by this paper
• Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly.

  2002cited by this paper
• Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program.

  2002cited by this paper
• Immune response to influenza vaccination in a large healthy elderly population.

  1999cited by this paper
• Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination.

  1999cited by this paper
• Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.

  1998cited by this paper
• Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled.

  1997cited by this paper
• The Efficacy of Influenza Vaccine in Elderly Persons

  1995cited by this paper
• An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination.

  1994cited by this paper
• HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992.

  1994cited by this paper

• Ageing and Liver Immune Cells.

  2026cites this paper
• Respiratory virus immune response in the aged host

  2026cites this paper
• Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine

  2025cites this paper
• Understanding and improving vaccine efficacy in older adults

  2025cites this paper
• Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID Patients

  2025cites this paper
• Immunoporosis: The hidden link between aging immune cells and bone fragility

  2025cites this paper
• Recent developments of vaccines for older adults: Adjuvants and beyond

  2025cites this paper
• Aging‐associated changes in immunological parameters: Implications for COVID‐19 immune response in the elderly

  2025cites this paper
• Zinc deficiency as possible link between immunosenescence and age-related diseases

  2025cites this paper
• Viral Infections in Elderly Individuals: A Comprehensive Overview of SARS-CoV-2 and Influenza Susceptibility, Pathogenesis, and Clinical Treatment Strategies

  2025cites this paper
• Memory Cells in Infection and Autoimmunity: Mechanisms, Functions, and Therapeutic Implications

  2025cites this paper
• Safety and immunogenicity of ascending doses of influenza A(H7N9) inactivated vaccine with or without MF59®.

  2025cites this paper
• Age-stratified circulating immune signatures reveal non-invasive biomarkers for colorectal cancer detection

  2025cites this paper
• Effects of repeated influenza vaccination and infection on durable seroprotection in healthcare workers

  2025cites this paper
• Immunosenescence and inflammaging: Mechanisms and modulation through diet and lifestyle

  2025cites this paper
• HIV infection and immunosenescence: challenges and intervention strategies

  2025cites this paper
• T and B cell responses following primary COVID-19 vaccination with CoronaVac and two heterologous BNT162b2 booster doses

  2025cites this paper
• Characteristics of neuraminidase-specific immune responses in influenza vaccinated or naturally infected populations in Shenzhen, China.

  2025cites this paper
• Multi-omic profiling reveals age-related immune dynamics in healthy adults

  2025cites this paper
• Recent clinical evidence on nutrition, novel pharmacotherapy, and vaccination in inflammatory bowel diseases

  2024cites this paper
• Understanding the Complex Dynamics of Immunosenescence in Multiple Sclerosis: From Pathogenesis to Treatment

  2024cites this paper
• Enhanced mitochondrial function in B cells from elderly type-2 diabetes mellitus patients supports intrinsic inflammation

  2024cites this paper
• Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors

  2024influential citation
• The COVID-19 Vaccine Gamble-By luck they worked in the oldest, frailest people.

  2024cites this paper
• Immunosenescence and Cytomegalovirus: Exploring Their Connection in the Context of Aging, Health, and Disease

  2024cites this paper
• Molecular and Cellular Mechanisms of Immunosenescence: Modulation Through Interventions and Lifestyle Changes

  2024cites this paper
• Immune aging and infectious diseases

  2024cites this paper
• Age-dependent immune profile in healthy individuals: an original study, systematic review and meta-analysis

  2024cites this paper
• Immunosenescence and Inflammaging: Mechanisms and Role in Diseases.

  2024cites this paper
• Longitudinal Multi-omic Immune Profiling Reveals Age-Related Immune Cell Dynamics in Healthy Adults

  2024cites this paper
• Tobacco exposure, but not aging, shifts the frequency of peripheral blood B cell subpopulations

  2023cites this paper
• Immune Response to Vaccination against COVID-19 at Different Second-Dose Intervals and Their Associations with Metabolic Parameters

  2023cites this paper
• From aging to long COVID: exploring the convergence of immunosenescence, inflammaging, and autoimmunity

  2023cites this paper
• Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration

  2023cites this paper
• The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence

  2023cites this paper
• Immune aging - A mechanism in autoimmune disease.

  2023cites this paper
• Systemic inflammation and biological aging in the Health and Retirement Study

  2023cites this paper
• Influenza Immunoglobulin (Ig) Y Derived from Chicken Egg Yolk: Production, Characterization, and Its Cross-Reactivity

  2023cites this paper
• Single-cell profiling reveals age-associated immunity in atherosclerosis

  2023cites this paper
• The effects of age on antibody response towards COVID-19 vaccination: A Systematic Review

  2023cites this paper
• The gastrointestinal-brain-microbiota axis: a promising therapeutic target for ischemic stroke

  2023cites this paper
• Microbial-Immune Crosstalk in Elderly-Onset Inflammatory Bowel Disease: Unchartered Territory.

  2023cites this paper
• A Review of the Potential Effects of Melatonin in Compromised Mitochondrial Redox Activities in Elderly Patients With COVID-19

  2022cites this paper
• Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine

  2022cites this paper
• Immunogenicity of BNT162b2, BBIBP-CorV, Gam-COVID-Vac and ChAdOx1 nCoV-19 Vaccines Six Months after the Second Dose: A Longitudinal Prospective Study

  2022cites this paper
• The diseased kidney: aging and senescent immunology

  2022cites this paper
• Distinct Molecular Signatures of Aging in Healthy and HIV-Infected Individuals

  2022cites this paper
• An old problem with new solutions: Strategies to improve vaccine efficacy in the elderly.

  2022cites this paper
• Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis

  2022cites this paper
• Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine

  2022cites this paper
• Host immune responses and possible therapeutic targets for viral respiratory tract infections in susceptible populations: a narrative review.

  2022cites this paper
• Immunoglobulin gene expression profiles and microbiome characteristics in periodontitis in nonhuman primates.

  2022cites this paper
• Cellular Senescence in Immunity against Infections

  2022cites this paper
• Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction

  2022cites this paper
• Antibody Persistence 6 Months Post-Vaccination with BNT162b2 among Health Care Workers

  2021cites this paper
• B and T Cell Immunity in Tissues and Across the Ages

  2021cites this paper
• The impact of immuno-aging on SARS-CoV-2 vaccine development

  2021cites this paper
• Sex-specific effects of age and body mass index on antibody responses to seasonal influenza vaccines in healthcare workers.

  2021cites this paper
• B‐cell capacity for differentiation changes with age

  2021cites this paper
• Sex-specific differences of humoral immunity and transcriptome diversification in older adults vaccinated with inactivated quadrivalent influenza vaccines

  2021cites this paper
• Aging, cancer, and antitumor immunity

  2021cites this paper
• The aging lung: Physiology, disease, and immunity

  2021cites this paper
• Vaccine responses in ageing and chronic viral infection

  2021influential citation
• SARS-CoV-2-specific memory B cells can persist in the elderly despite loss of neutralising antibodies

  2021cites this paper
• Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine

  2021cites this paper
• The potential of cord blood to replenish young immune cells against cancer

  2021cites this paper
• Early Onset of SARS-COV-2 Antibodies after First Dose of BNT162b2: Correlation with Age, Gender and BMI

  2021cites this paper
• Inferior outcomes in lung transplant recipients with serum Pseudomonas aeruginosa specific cloaking antibodies.

  2021cites this paper
• COVID-19 vaccines in elderly subjects: Considerations on efficacy and safety

  2021cites this paper
• Impaired memory B-cell recall responses in the elderly following recurrent influenza vaccination

  2021influential citation
• Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?

  2021cites this paper
• Vaccination of older adults: Influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond

  2021cites this paper
• Characterization of aging-related changes in human hematopoietic stem cells

  2021cites this paper
• Current Insights into the Host Immune Response to Respiratory Viral Infections.

  2021cites this paper
• Interconnections between Inflammageing and Immunosenescence during Ageing

  2021cites this paper
• Vaccines and Vaccination Strategies for Older Adults

  2021cites this paper
• How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19

  2021cites this paper
• [Immunosenescence, viral infections and nutrition: A narrative review of scientific available evidence].

  2021cites this paper
• SARS-CoV-2–specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies

  2021cites this paper
• Influenza Vaccination in Older Adults

  2021cites this paper
• Rebalancing the unbalanced aged immune system - a special focus on zinc.

  2021cites this paper
• Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines

  2021cites this paper
• Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives

  2020cites this paper
• ПОЛИМОРБИДНОСТЬ, СТАРЕНИЕ ИММУННОЙ СИСТЕМЫ И СИСТЕМНОЕ ВЯЛОТЕКУЩЕЕ ВОСПАЛЕНИЕ – ВЫЗОВ СОВРЕМЕННОЙ МЕДИЦИНЕ Ширинский

  2020cites this paper
• Approaches to vaccine prophilaxis of respiratory infections in patients with diabetes mellitus in the modern epidemiological situation

  2020cites this paper
• Efficacy and safety of COVID-19 vaccines in older people

  2020cites this paper
• The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab

  2020cites this paper
• DYSBIOSIS, MALNUTRITION AND ENHANCED GUT-LUNG AXIS CONTRIBUTE TO AGE-RELATED RESPIRATORY DISEASES.

  2020cites this paper
• Understanding immunosenescence and its impact on vaccination of older adults.

  2020cites this paper
• Aging induces B cell defects and decreased antibody responses to influenza infection and vaccination

  2020cites this paper
• Effect of age and sex on immune checkpoint expression and kinetics in human T cells

  2020cites this paper
• The Corrective Effect of Fucoidan, a Sulfated Polysaccharide Extracted from Brown Algae Fucus evanescens, in the Formation of a Specific Immune Response Against Seasonal Influenza Viruses in the Elderly

  2020cites this paper
• CNS and peripheral immunity in cerebral ischemia: partition and interaction.

  2020cites this paper
• B Cell Immunosenescence.

  2020influential citation
• Defective early innate immune response to ectromelia virus in the draining lymph nodes of aged mice due to impaired dendritic cell accumulation

  2020cites this paper
• COVID-19 and Crosstalk With the Hallmarks of Aging

  2020cites this paper
• The Corrective Effect of Fucoidan, a Sulfated Polysaccharide Extracted from Brown Algae Fucus evanescens, in the Formation of a Specific Immune Response Against Seasonal Influenza Viruses in the Elderly

  2020cites this paper
• Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19

  2020cites this paper
• Age‐related factors that affect B cell responses to vaccination in mice and humans

  2020cites this paper
• Why does COVID-19 disproportionately affect older people?

  2020cites this paper